News
1don MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...
The Trump administration’s decision to yank nearly $600 million in promised bird flu vaccine funding is the latest worrying ...
The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results